Lack of randomized placebo-controlled studies and heterogenicity in study design hampers generalized statements about the effects of COCs on sexual function. Despite these challenges, consideration of sexual dysfunction when presenting and prescribing hormonal contraception is essential for informed consent, shared decision making, and ensuring reliable contraceptive choices.
Keyphrases
- placebo controlled
- double blind
- phase iii
- phase ii
- primary care
- clinical trial
- study protocol
- phase ii study
- oxidative stress
- mental health
- estrogen receptor
- polycystic ovary syndrome
- case control
- case report
- open label
- adverse drug
- squamous cell carcinoma
- emergency department
- adipose tissue
- insulin resistance
- locally advanced
- electronic health record